• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Why Tandem Diabetes Care Stock Was Zooming Higher Today

cafead

Administrator
Staff member
  • cafead   Mar 26, 2024 at 04:42: PM
via
  • An analyst upgraded his recommendation on the diabetes care specialist.
  • He now rates it a buy, with potential 11% upside to the current share price.

article source
 

<